OxC-beta supply agreement with Avivagen in the United States, Brazil and Thailand

We have become the exclusive distributor of OxC-beta^TM for use with poultry, swine, ruminants (dairy and beef) and aquaculture in United States, Brazil and Thailand. The transformative eight-year supply agreement is expected to increase OxC-Beta^TM access and adoption in the largest feed production markets worldwide.

“This is a truly transformative partnership for Avivagen, and one that stands to benefit not only us and AB Vista but feed and livestock producers in the Americas and Asia as well,” says Kym Anthony, Chief Executive Officer, Avivagen Inc. “We’ve had a lot of interest from potential partners for OxC-beta^TM, but AB Vista’s expertise and track record set it apart. With their industry-leading technical knowledge and know-how we are confident that this agreement will drive considerable adoption of OxC-beta^TM and growth for Avivagen over the better part of the next decade.”

As a part of the agreement, we will also collaborate with Avivagen on future development efforts, including advancing opportunities for OxC-beta^TM use for aquaculture purposes (such as shrimp production). Aquaculture represents a new category for OxC-beta^TM use, following considerable success with poultry, swine and ruminants in markets worldwide.

“We pride ourselves on bringing pioneering, high-value products and services to the global animal feed market. We believe OxC-beta^TM could be one of the next great innovations and advancements in animal nutrition, and we’re excited to be able to deliver this great product to our customers,” says our Managing Director, Juan Ignacio Fernandez.

“Based on the extensive technical data supporting the role OxC-beta^TM can have in reducing production reliance on antibiotics, we are confident our customers in the United States, Brazil and Thailand will have high demand for such a differentiated product.”